EUVIMEDEUVIMED entdecken
Open Access

Between Achievement and Challenge: Examining China's Tuberculosis Control Pathway and Future Directions from a Global Perspective

Yanqiu Zhang, Dingyong Sun, Linqi Diao

China CDC Weekly · 2026 · 8 (21) · 666-671

DOI: 10.46234/ccdcw2026.108 ↗

Kurz gefasst

Fachartikel in der Zeitschrift China CDC Weekly, 2026. Verfasst von Yanqiu Zhang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Henan Key Laboratory of Infectious Pathogenic Microbiology, Henan Provincial Center for Disease Control and Prevention, Zhengzhou City, Henan Provinc…. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The World Health Organization (WHO) Global Tuberculosis Report 2025 (the Report) was released on November 12, 2025, covering disease burden, diagnosis and treatment, prevention and screening, financing, universal health coverage (UHC), multisectoral accountability, research and innovation, and provides the latest benchmark for global tuberculosis (TB) prevention and control.The Report indicates that China's incidence rate has, for the first time, entered the category of lower moderate-burden countries.China has made significant progress in expanding coverage of rapid diagnostic technologies and increasing domestic financing.Its strategy and implementation model for scaling up TB preventive treatment (TPT) have been recognized as an international best practice, although current coverage among household contacts remains below the global average.However, global comparisons also reveal that China continues to face challenges in narrowing the case detection gap, improving the bacteriological positivity rate, addressing the high burden of drugresistant (DR) TB, and mitigating the economic risks for affected households.These challenges are similar to those in high-burden countries.This perspective uses the Report's structured framework to conduct a systematic comparative analysis of global trends and China's TB control landscape.It aims to review China's achievements and challenges and, drawing on global consensus and local practices, propose strategic priority actions necessary for China to advance toward the goal of ending the TB epidemic. THE GLOBAL TB EPIDEMIC AND CHINA'S POSITIONThe Global Tuberculosis Report 2025 (the Report) (1) indicates that global tuberculosis (TB) control is at a critical turning point.Following the impact of the COVID-19 pandemic, the estimated global TB incidence rate stood at 131 cases per 100,000 population in 2024, marking a marginal decrease of approximately 2% for the first time, with an estimated 10.7 million new cases.However, this progress remains fragile and uneven, and a significant gap remains in achieving the ambitious goal of ending the TB epidemic.The estimated TB incidence rate in China was 49 per 100,000 population in 2024 (approximately 696,000 cases).China has dropped from third to fourth place among the 30 high TB burden countries, and its incidence rate has entered the lower moderateburden category for the first time, demonstrating China's contribution to global TB control and prevention.Within the global context, China's position remains pivotal.TB cases in China account for approximately 6.5% of cases globally.However, in the more severe domain of multidrug-resistant or rifampicin-resistant TB (MDR/RR-TB), China ranks second-highest globally, contributing 7.1% of MDR/RR-TB cases.China faces the complex task of ensuring rapid diagnosis and effective, affordable treatment for drug-resistant cases.The effectiveness of its control efforts will directly influence global MDR/RR-TB trends, underscoring both its responsibility and challenges.The Report categorizes global response actions into six core components.Table 1 presents key indicators for both global and Chinese contexts.

Schlagwörter

Stichwörter der Autor:innen

ChinaDiagnosisFinancingGlobal ReportPreventionTuberculosis

Autor:innen und Institutionen

  • Henan Key Laboratory of Infectious Pathogenic Microbiology, Henan Provincial Center for Disease Control and Prevention, Zhengzhou City, Henan Province, China.

Zitieren

APA

Zhang, Y., Sun, D., & Diao, L. (2026). Between Achievement and Challenge: Examining China's Tuberculosis Control Pathway and Future Directions from a Global Perspective. China CDC Weekly, 8(21), 666-671. https://doi.org/10.46234/ccdcw2026.108

Vancouver

Zhang Y, Sun D, Diao L. Between Achievement and Challenge: Examining China's Tuberculosis Control Pathway and Future Directions from a Global Perspective. China CDC Weekly. 2026;8(21):666-671. doi:10.46234/ccdcw2026.108

BibTeX
@article{Zhang2026,
  author = {Zhang, Yanqiu and Sun, Dingyong and Diao, Linqi},
  title = {Between Achievement and Challenge: Examining China's Tuberculosis Control Pathway and Future Directions from a Global Perspective},
  journal = {China CDC Weekly},
  year = {2026},
  volume = {8},
  number = {21},
  pages = {666--671},
  doi = {10.46234/ccdcw2026.108}
}
Kostenlos starten →